| Rapamune Side Effect Report | Date Submitted |
|---|---|
| fatigue, bleeding nose, bad cough, tightness of ch | 2010-07-25 |
| severe acne: have to treat it with oral medication | 2009-09-03 |
Rapamune Side Effect Reports Summary
PatientsVille.com - Empowering Patients
Rapamune Studies
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Controlled Level EVERolimus in Acute Coronary Syndromes
Topical Rapamycin to Erase Angiofibromas in TSC
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Sirolimus Injections for Autoimmune Scleritis
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
The Rosuvastatin In TrAnsplant Recipients Study
Phase II Study of Alternating Sunitinib and Temsirolimus
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)
Everolimus Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (Gastro Intestina
Efficacy and Safety Study of RAD001 in the Growth of the Vestibular Schwannoma(s) in Neurofibromatosis 2 (NF2) Patients
Gastric Cancer RAD001 Study
Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Study of Axitinib and Temsirolimus in Solid Tumors
Pasireotide, Everolimus and Selective Internal Radioemobilization Therapy for Unresectable Hepatic Metastases
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan)
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leuk
A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor
Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed
Combination Trial MSC1936369B With Temsirolimus
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Vinorelbine Ditartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome
Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-
Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Docetaxel and Sirolimus in Patients With Advanced Malignancies
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Li
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EG
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Sirolimus and Cetuximab in Advanced Malignancies
Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic S
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Registry for Temsirolimus and Sunitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), and Gastro-Intestinal Stroma T
Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment
Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
You took Rapamune and now feel unusual symptoms. It could be Rapamune side effect. Help Community - Submit Your Side Effect.
Mobile version
How Did You Deal with Side Effects?About Rapamune : Risks and Benefits, News and Updates, Rapamune video and TV resources<<<<
Rapamune Side Effects - Complete Patient's Guide | User Reviews: Male patient, child 11 years of age, was |Peripheral Edema|Hot/cold Body Temps|Red Spots|Excessive ...<<<<
Rapamune Side Effects Reported and Ranked by Rapamune Users |Peripheral Edema|Hot/cold Body Temps|Red Spots|Excessive Itching, Mouth Ulcers | Rapamune Reviews ...<<<<
rapamune Episodes: 4: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: remicade Episodes: 3: Diagnosed with major depression.Side ...<<<<
Hi my son son has KHE and has just started treatment June 2011 for it with sirolimus(rapamune) and now it is November 2011 and it has shrunk his tumor significantly.<<<<
Rapamycin, also known as sirolimus and sold by Wyeth as Rapamune, is used to coat J&J’s Cypher stent. Wyeth and J&J claimed Abbott, based in Abbott Park, Illinois, and ...<<<<
Rapamycin, also known as sirolimus and sold by Wyeth as Rapamune, is used to coat J&J’s Cypher stent. Wyeth and J&J claimed Abbott, based in Abbott Park, Illinois, and ...<<<<
rapamune Episodes: 2: Diagnosed with major depression.Side effects: cardiac failure, myocarditis More: raptiva Episodes: 2: Diagnosed with major depression.Side ...<<<<
The urinary system consists of the kidneys, ureters, bladder and urethra.<<<<
A pulmonary embolism is a sudden blockage in a lung artery. The ... About Us PatientsVille.com is the leading Health 2.0 provider of consumer-reported drug side ...<<<<